FDA Investigator Kent A Conforti

Kent A Conforti has conducted inspections on 256 sites in 14 countries as of 20 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
256
Last Inspection Date:
20 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Hungary, India, Finland, Greece, Dominican Republic, Canada, South Africa, Bulgaria, Poland, Austria, United Kingdom of Great Britain and Northern Ireland, Spain, Brazil
FDA Investigators that have inspected at least one site in common with Kent A Conforti:
Aaron L Morris, Abby E Pelletier, Aisha P Johnson, Alan R Condon, Aldo J Quintana, Alfred P Pistorio, Alice C Silva, Alicia A Dalley, Alissa E Berryman, Allison A Aldridge, PhD, Alois P Provost, Alysia M Salonia, Amber G Wardwell, Amy C Jordan, Andrace L Deyampert, Andrew J Seaborn, Andrew M Barlow, Angela Shepas, Anne E Carpenter, Anthony C Warchut, Anthony N Onianwa, Anthony W Thomas, Arindam Dasgupta, PhD, Ashley J Burns, Ashley M Whitehurst, Asia D Clark, Atricia L Irons, Barbara D Wright, Bradley D Newsad, Brenda P King, Byungja E Marciante, Carl A Huffman, III, Carla C Tuite, Charles A Snipes, PhD, Charles R Bonapace, PhD, Charles R Cote, RIC, Cheryl A Grandinetti, Christine M Whitby, CSO, Christopher Janik, Christopher K Vantwuyver, Christopher M Elliott, Chunsheng Cai, PhD, Constance Desimone, Courtney N Long, Danielle S Pearson, Darin S Wiegers, Daryl A Dewoskin, David A Lepay, MD, PhD, David J Feria, David M Lamoureux, David P Vanhouten, Dawn C Olenjack, Dawn M Braswell, Diane C Thibodeau, Diane L Raccasi, Diane M Prince, Diantha M Bleau, Dien N Nguyen, Dominic R Frasca, Dorothy W Lee, Douglas S Joslin, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Eduardo L Rodriguez, Edward J Janik, Elizabeth B Griffin, Ellen P Madigan, Emily J Schramm, Erin P Conlin, Gabrielle J Swain, Garry H Stewart, Gary J Hagan, Gayle S Lawson, Gerard D Difiore, Haley H Seymour, Hang N Guo, Hien Albright, Hugh M Mcclure, II, Jack Ragheb, James H Tanner, James P Finn, James W Whitney, Jamie S Mathews, Janete F Guardia, Jason A Rossi, Jason D Tenney, Jeffrey J Thibodeau, Jennifer Adams, MPH, Jennifer C Adams, Jessica D Spellman, Jianming Li, John A Sciacchitano, John J Thibodeau, John L Zaccone, John P Mistler, John P Shelton, John S Hartford, Jonah S Ufferfilge, Jonathan B Lewis, Jonathan G Matrisciano, Joppie, Jorge E Martinez, Jose A Torres, Jose Acruz Gonzalez, Jose Ohernandez Guzman, Joseph T Frost, Joshua D Levin, Joyce A Kellett, Julie D Bringger, Justina O Tam, Justine M Corson, Karen M Kondas, Karen Mcnabb Noon, Kathleen E Mcafoose, Kathleen M Curry, Kathryn Suttling, La Tasham Gunter, Lauren Iacono Connors, PhD, Lauren M Lawrance, Laurie B Frazier, LCDR Debra Emerson, Leena Thomas, Leo B Zadecky, Li Hongpaul Yeh, PhD, Linda L Green, Linda M Hoover, Lloyd D Payne, Lorayne A Mcguinness, Lori A Holmquist, Lori M Newman, Lori Peters, Louis Christy, LTJG Bradley E Benasutti, Lucie Yang, Marcia M Laughrey, Margaret E Walsh, Margaret M Sands, Marilyn Welchenbach, Mark K Tseng, Mark R Mcclain, Marlene L Davis, Martin J Guardia, Mary E Baker Brown, Mary Jeanet Mcgarry, Mary T Carden, Matthew C Watson, Maura Rooney, Maya M Davis, Mayar M Mussa, Megan A Haggerty, Melkamu Getie Kebtie, PhD, Meredith L Miller, Michael E Antaya, Michael G Mayfield, Michael J Leal, Michael P Anthony, Michael Serrano, Michele M Falchek, Michelle M Noe Varga, Michelle S Anantha, Michelle Yclark Stuart, Monique C Lo, Nabil Nakhoul, Nadeem I Chaudhry, Nancy A Bellamy, Nasser Yazdani, DVM, MPH, Nealie C Newberger, Nichole B Murphy, Nicola M Fenty Stewart, Nina Yang, Nisha C Patel, Osama A Khatib, Pamela L Ogonowski, Paraluman S Leonin, Patricia A Clark, Paul E Stein, Paul P Geraci, Paula M Laplant, Peter R Lenahan, Philip Kreiter, Phillip D Kronstein, MD, Ramcharan S Khalsa, Ramon E Martinez, Rapti D Madurawe, Rebecca Rodriguez, Richard F Hapke, Richard H Penta, Richard L Licari, Richard W Berning, Robert J Martin, Robert O'brian, Rory K Geyer, Rupa Pradhan, Sandra P White, Sara M Onyango, Sara M Richardson, Scott B Laufenberg, Scott N Lim, Sean M Tessicini, Sean R Marcsisin, Sereen Gmorgan Murray, Sherri N Rohlf, MD, Sherry M Nisson, Sripal R Mada, PhD, Stacey S Degarmo, Stephanie M Roberts Pedotti, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen R Souza, Stuart W Russell, Susan D Yuscius, Susan Kirshner, Susanne M Richardson, MS RAC, Suwaskie S Smith, Sylvia A Craven, Tamara M Kays, Teddy Tom, Thomas Cote, Thomas J Arista, Thomas Siebertz, Thomas W Gordon, Thomas W Nerney, Timothy M Glod, Troy R Petrillo, Tyanna N Hadley, Victor J Gangi, Victoria D'addeo, Victoria M Daddeo, Victoria Taylor, Vlada Matusovsky, William K Dagley

Kent A Conforti's Documents

Publish Date Document Type Title
August, 2018 FDA 483 Dr. Sandeep Kumar Gupta - Form 483, 2018-08-31
January, 2020 FDA 483 Wayne G. Shreffler, M.D. - Form 483, 2020-01-31
May, 2013 FDA 483 Sunovion Pharmaceuticals Inc. - Form 483, 2013-05-24
January, 2019 EIR Labcorp Bedford LLC. - EIR, 2019-01-24
March, 2024 FDA 483 GE Healthcare Inc. - Life Sciences - Form 483, 2024-03-08
April, 2019 FDA 483 Maria Alora Palli, M.D. - Form 483, 2019-04-29
October, 2018 EIR AMAG Pharmaceuticals, Inc. - EIR, 2018-10-22
March, 2021 FDA 483 Kaleido Biosciences, Inc. - Form 483, 2021-03-03
April, 2018 EIR Sarepta Therapeutics, Inc. - EIR, 2018-04-12
June, 2021 FDA 483 Douglas Terp - Form 483, 2021-06-28
March, 2023 FDA 483 Maryellen Fitzgerald, M.D. - Form 483, 2023-03-10
May, 2019 FDA 483 Concord Biomedical Science and Emerging Technologies, Inc. - Form 483, 2019-05-23
August, 2018 FDA 483 Sanjay Gupta - Form 483, 2018-08-24
September, 2014 FDA 483 Scott Alan Wilson, M.D. - Form 483, 2014-09-10
April, 2022 FDA 483 Inci B. Yildirim, M.D. - Form 483, 2022-04-15
August, 2019 FDA 483 David L. Diuguid, M.D. - Form 483, 2019-08-02
October, 2021 EIR Karen D. Wright, M.D. - EIR, 2021-10-18
February, 2023 FDA 483 Francine M. Foss - Form 483, 2023-02-03
July, 2018 FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc. - Form 483, 2018-07-03
February, 2021 FDA 483 Aditya Bardia, M.D. - Form 483, 2021-02-08
September, 2016 FDA 483 Krzysztof W. Selmaj, M.D., Ph.D. - Form 483, 2016-09-23
June, 2017 FDA 483 Pfizer Laboratories Div Pfizer Inc - Form 483, 2017-06-28
October, 2022 FDA 483 Elizabeth I. Buchbinder, M.D. - Form 483, 2022-10-09
March, 2022 EIR Servier Pharmaceuticals, LLC. - EIR, 2022-04-06
September, 2017 FDA 483 Response Pfizer Inc. Groton Laboratories - Form 483R, 2017-09-22
November, 2016 FDA 483 Radius Health, Inc. - Form 483, 2016-11-14
October, 2008 FDA 483 Resilience US, Inc. - Form 483, 2008-10-10
February, 2018 FDA 483 Jane Metrik, Ph.D. - Form 483, 2018-02-14
June, 2015 EIR Charles River Laboratories Montreal ULC - EIR, 2015-06-12
January, 2019 FDA 483 Labcorp Bedford LLC. - Form 483, 2019-01-24
October, 2015 FDA 483 Michael L. Rossen - Form 483, 2015-10-30
May, 2017 FDA 483 Mass General Brigham Inc. IRB - Form 483, 2017-05-23
March, 2016 EIR MaineHealth IRB #1 - EIR, 2016-03-16
April, 2023 FDA 483 Aldeyra Therapeutics, Inc. - Form 483, 2023-05-01
May, 2019 EIR Concord Biomedical Science and Emerging Technologies, Inc. - EIR, 2019-05-23
December, 2020 FDA 483 Caron Jacobson, Md - Form 483, 2020-12-16
March, 2015 FDA 483 Karl Zuzarte - Form 483, 2015-03-26
July, 2022 EIR ImmunoGen, Inc. - EIR, 2022-07-28
March, 2019 FDA 483 TransMedics, Inc. - Form 483, 2019-03-14
August, 2023 FDA 483 Andrew C. Siesennop, MD - Form 483, 2023-08-04
May, 2018 FDA 483 Response Charles Stephen Foster, M.D. - Form 483R, 2018-05-21
May, 2022 EIR bluebird bio, Inc. - EIR, 2022-05-06
June, 2010 FDA 483 American Red Cross Blood Services - Form 483, 2010-06-15
September, 2019 EIR Blueprint Medicines Corporation - EIR, 2019-09-05
May, 2018 EIR Charles Stephen Foster, M.D. - EIR, 2018-06-08
August, 2020 FDA 483 Monica E. Kleinman, M.D. - Form 483, 2020-08-25
June, 2017 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2017-06-28
September, 2017 FDA 483 Pfizer Inc. Groton Laboratories - Form 483, 2017-09-22
September, 2021 FDA 483 Labcorp Bedford LLC. - Form 483, 2021-10-25
December, 2022 FDA 483 Nezabravka Petrova Haytova - Form 483, 2022-12-16
August, 2023 FDA 483 Lumicell, Inc. - Form 483, 2023-08-18
October, 2008 FDA 483 Response Resilience US, Inc. - Form 483R, 2008-10-31
April, 2018 FDA 483 Sarepta Therapeutics, Inc. - Form 483, 2018-04-12
September, 2017 EIR Pfizer Inc. Groton Laboratories - EIR, 2017-09-22
March, 2019 FDA 483 Purdue Pharma L.P. - Form 483, 2019-03-29
March, 2016 FDA 483 MaineHealth IRB #1 - Form 483, 2016-03-16
April, 2009 FDA 483 CBI - Form 483, 2009-04-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more